Cloud-Connected Automated Intravenous (IV) Compounding Market Growth Is Accelerating As Industry Transformation Continues
Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Cloud-Connected Automated Intravenous (IV) Compounding Market Forecast: What Market Value Is Expected By 2030?
The cloud-connected automated intravenous (IV) compounding market has expanded significantly over recent years. Its value is forecast to increase from $2.34 billion in 2025 to $2.73 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 16.8%. Historically, this expansion has been driven by several factors, including the rising adoption of automated IV compounding systems, an increasing demand for medication safety and accuracy, greater hospital investments in pharmacy automation, the expansion of oncology and specialized treatment centers, and a heightened awareness of sterile compounding standards.
The cloud-connected automated intravenous (IV) compounding market is projected to experience substantial growth in the upcoming years. It is anticipated to expand to $5.03 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 16.5%. This growth throughout the forecast period can be attributed to the rising integration of cloud-based monitoring solutions, the advancing development of AI-powered error detection systems, increased investment in compact and modular robotic designs, the expansion of homecare and decentralized pharmacy applications, and a heightened focus on interoperability and data analytics platforms. Prominent trends for the forecast period include technological advancements in cloud-connected workflow management, innovations in AI and machine learning for predictive compounding, the creation of smart consumables and sensors, dedicated research and development in oncology-specific automation solutions, and strategic investment in scalable and remote monitoring deployment models.
Download A Free Sample Report For Comprehensive Market Insights:
Cloud-Connected Automated Intravenous (IV) Compounding Market Expansion Supported By Key Demand Factors
The escalating need for biosimilars is projected to fuel the expansion of the cloud-connected automated IV compounding market moving forward. Biosimilars are biologic medical products that exhibit high similarity to an already approved reference biologic, demonstrating no clinically significant distinctions in terms of safety, purity, or efficacy. The growing requirement for biosimilars is attributed to their greater cost-effectiveness compared to branded biologics. Automated IV compounding enhances the secure and precise preparation of biosimilars by minimizing human error, guaranteeing accurate dosing, and preserving product integrity. For instance, in January 2023, according to Cardinal Health Inc., a US-based healthcare company, the U.S. had 33 FDA-approved biosimilar products as of January 2022, with 21 available on the market, and by 2023, this figure rose to 40 FDA-approved biosimilars, 25 of which were commercially available. Consequently, the rising demand for biosimilars is a key impetus for the cloud-connected automated IV compounding market.
Cloud-Connected Automated Intravenous (IV) Compounding Market Segment Landscape: Which Areas Lead Market Development?
The cloud-connected automated intravenous (iv) compounding market covered in this report is segmented –
1) By Product Type: Robotic Compounding Systems, Software Solutions, Consumables
2) By Deployment Mode: Cloud-Hosted Deployment, Hybrid Cloud Deployment, On-Premise With Cloud Integration
3) By Application: Hospital Pharmacies, Oncology Centers, Homecare Settings, Other Applications
4) By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Robotic Compounding Systems: Automated Intravenous Preparation Robots, Modular Robotic Compounding Units, Sterile Compounding Robotic Arms, Integrated Safety Monitoring Systems
2) By Software Solutions: Workflow Management Software, Inventory Management Software, Dose Verification Software, Remote Monitoring And Analytics Software
3) By Consumables: Sterile Syringes, Intravenous Bags, Vials And Ampoules, Filters And Tubing Sets, Protective Personal Equipment
Cloud-Connected Automated Intravenous (IV) Compounding Market Growth Trends Influencing Competitive Dynamics
Leading companies within the cloud-connected automated intravenous (IV) compounding market are prioritizing enhancements to automated systems, such as cloud-enabled monitoring and compliance tracking, to boost sterile preparation accuracy, decrease medication errors, and strengthen regulatory adherence. Cloud-enabled monitoring and compliance tracking involves integrated software and hardware features that allow healthcare facilities to access real-time data on IV compounding processes, maintain electronic audit trails, and ensure adherence to sterility and quality standards across various sites. As an illustration, in May 2025, the United States Food and Drug Administration (FDA), a US-based regulatory authority, highlighted updated guidance and enforcement initiatives under section 503B of the Federal Food, Drug, and Cosmetic Act, which mandates outsourcing facilities to maintain rigorous quality control and documentation for compounded sterile products. These directives promote the adoption of automated IV compounding systems equipped with cloud-based monitoring, electronic record-keeping, and remote quality oversight functionalities.
Cloud-Connected Automated Intravenous (IV) Compounding Market Industry Leaders And Market Competition
Major companies operating in the cloud-connected automated intravenous (iv) compounding market are McKesson Corporation, Becton Dickinson and Company, Baxter International Inc., B. Braun Melsungen SE, Fresenius Kabi AG, Grifols S.A., ICU Medical Inc., Syntegon Technology GmbH, Omnicell Inc., Marchesini Group S.p.A., Swisslog Healthcare, ScriptPro LLC, Parata Systems LLC, ARxIUM Inc., Equashield LLC, Health Robotics S.r.l., Rommelag AG, NewIcon Oy, DoseEdge, Aesynt Inc.
Access The Complete Cloud-Connected Automated Intravenous (IV) Compounding Market Report:
Cloud-Connected Automated Intravenous (IV) Compounding Market Regional Outlook: Where Are The Largest Opportunities Located?
North America was the largest region in the cloud-connected automated intravenous (IV) compounding market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cloud-connected automated intravenous (iv) compounding market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
